Jane Street Group, LLC Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2025 Nov 13, 2025	BUY	$0.27 - $0.54 $15,093 - $30,186	55,900 Added 93.32%	115,800 $42,000
Q2 2025 Aug 14, 2025	SELL	$0.34 - $1.12 $3,468 - $11,424	-10,200 Reduced 14.55%	59,900 $22,000
Q1 2025 May 14, 2025	SELL	$0.95 - $2.08 $49,305 - $107,952	-51,900 Reduced 42.54%	70,100 $66,000
Q4 2024 Feb 14, 2025	BUY	$0.92 - $2.82 $112,240 - $344,040	122,000 New	122,000 $211,000

9.74M

585K

31.6K

Ticker RVPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,442,900
Market Cap $10.2M
Description
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.